1. Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes
   Liza C. Villaruz et al, 2016, European Journal of Cancer CrossRef
2. Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment
   Corey J. Langer et al, 2015, Clinical Lung Cancer CrossRef
3. In vivo synergistic anti-tumor effect of lumefantrine combined with pH responsive behavior of nano calcium phosphate based lipid nanoparticles on lung cancer
   Vaidevi Sethuraman et al, 2021, European Journal of Pharmaceutical Sciences CrossRef
4. Impact des traitements utilisés en oncologie thoracique sur la fonction rénale
   A.-C. Toffart et al, 2014, Revue des Maladies Respiratoires CrossRef
5. Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment
   René J. Boosman et al, 2021, International Journal of Cancer CrossRef
6. Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
   Margarita Majem et al, 2022, Global & Regional Health Technology Assessment CrossRef